Rosenblatt Maintains Buy on Dolby Laboratories, Maintains $98 Price Target
Dolby Laboratories, Inc. Class A -1.32%
Dolby Laboratories, Inc. Class A DLB | 73.28 | -1.32% |
Rosenblatt analyst Steve Frankel maintains Dolby Laboratories (NYSE:
DLB) with a Buy and maintains $98 price target.